Management of diabetes in patients with COVID-19
- PMID: 32707112
- PMCID: PMC7373399
- DOI: 10.1016/S2213-8587(20)30235-7
Management of diabetes in patients with COVID-19
Comment in
-
Management of diabetes in patients with COVID-19 - Authors' reply.Lancet Diabetes Endocrinol. 2020 Aug;8(8):669-670. doi: 10.1016/S2213-8587(20)30223-0. Lancet Diabetes Endocrinol. 2020. PMID: 32707113 Free PMC article. No abstract available.
Comment on
-
Practical recommendations for the management of diabetes in patients with COVID-19.Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23. Lancet Diabetes Endocrinol. 2020. PMID: 32334646 Free PMC article. Review.
References
-
- Anguiano L, Riera M, Pascual J, Soler MJ. Circulating ACE2 in cardiovascular and kidney diseases. Curr Med Chem. 2017;24:3231–3241. - PubMed
-
- Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 2008;74:1610–1616. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
